Sanofi-Aventis v. Pfizer Inc. (Fed. Cir. 2013)
By EsqSocial Corporation 15/11/13
Last week, in Sanofi-Aventis v. Pfizer Inc., the Federal Circuit affirmed an award of priority to Pfizer by the Board of Patent Appeals and Interferences in an interference involving the cDNA for the human interleukin-13 receptor binding chain...
By: McDonnell Boehnen Hulbert & Berghoff LLP